| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/18/2012 | CN102319266A krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 01/18/2012 | CN102319216A Insulin liposome lyophilized powder, oral insulin compound preparation and preparation methods and applications thereof |
| 01/18/2012 | CN102319206A Stable aqueous solution of recombinant human interleukin-11, and preparation method thereof |
| 01/18/2012 | CN101721684B Immunowakeup microsystem as well as preparation method and application thereof |
| 01/18/2012 | CN101607080B Oral drug for treating diabetes and preparation method thereof |
| 01/18/2012 | CN101590223B SOD complex capsule and preparation method thereof |
| 01/18/2012 | CN101530608B Composition with functions of resisting radiation and improving skin moisture |
| 01/18/2012 | CN101522195B Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
| 01/18/2012 | CN101514355B Method for preparing wheat germ protein ACE inhibitory peptide by continuous enzymolysis and ultra-filtration separation coupling |
| 01/18/2012 | CN101491670B Method for treating cardiovascular disease using nervous regulation protein and composite |
| 01/18/2012 | CN101448931B Microorganism capable of producing gamma-L-PGA, method for production of gamma-L-PGA using the microorganism, crosslinked product, and agent for external application to the skin |
| 01/18/2012 | CN101239180B Complexes for target killing tumor cell, preparation and application thereof |
| 01/17/2012 | US8097702 Cytokine polypeptide for use in treatment and prevention of viral and cell proliferative disorders |
| 01/17/2012 | US8097698 Derivatives of GLP-1 analogs |
| 01/17/2012 | US8097697 Tumor antigen protein SART-3 and tumor antigen peptides thereof |
| 01/17/2012 | US8097647 Augmented cognitive training |
| 01/17/2012 | US8097598 Porcine CTLA-4 for xenograft-specific immunosuppression |
| 01/17/2012 | US8097590 Melanocyte Stimulating Hormone; new peptides and peptidic conjugates containing at least 6 amino acids and including the sequence DPhe-Arg have a substantial activating effect on melanogenesis in the melanocytes of the hair bulb |
| 01/17/2012 | US8097589 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting mucous release into airways of patients; immunotherapy |
| 01/17/2012 | US8097588 Trophinin-binding peptides and uses thereof |
| 01/17/2012 | US8097587 IGF-I protein variants for treating IGFBP-1-related disorders |
| 01/17/2012 | US8097586 Modified exedins and uses thereof |
| 01/17/2012 | US8097585 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation |
| 01/17/2012 | US8097584 Therapeutic mixture comprising insulin, ethylenediamine and an antimicrobial preservative; improved chemical and storage stability |
| 01/17/2012 | US8097583 Proteins of natural origin and materials made therefrom |
| 01/17/2012 | US8097582 Peptide derivatives useful as antimicrobial agents and for treating wounds |
| 01/17/2012 | US8097581 Anti-wrinkle cosmetic composition |
| 01/17/2012 | US8097442 Laccases, nucleic acids encoding them and methods for making and using them |
| 01/17/2012 | US8097423 MN/CA IX and breast cancer therapy |
| 01/17/2012 | US8097274 Skin substitutes, preparation methods and uses thereof |
| 01/17/2012 | US8097262 Gel type enteral nutrient |
| 01/17/2012 | US8097257 MAGE3 polypeptides |
| 01/17/2012 | US8097255 Mammalian receptor protein DCRS5; methods of treatment |
| 01/17/2012 | US8097254 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 01/17/2012 | US8097253 Methods for inhibiting angiogenesis |
| 01/17/2012 | US8097252 Methods and compositions for administering therapeutic and diagnostic agents |
| 01/17/2012 | US8097242 Using cancer antigen 125 as tool in generating transmembrane serine protease inhibitory compound for treatment of urogenital cell proliferative disorders |
| 01/17/2012 | US8097241 Formulation and method for treating animal waste |
| 01/17/2012 | US8097238 Cell targeting conjugates |
| 01/17/2012 | CA2514152C Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis |
| 01/17/2012 | CA2482440C Oligomeric compounds having modified phosphate groups |
| 01/17/2012 | CA2465007C Methods and means for producing proteins with predetermined post-translational modifications |
| 01/17/2012 | CA2451353C Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 01/17/2012 | CA2446390C Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 01/17/2012 | CA2441958C Il-28 polypeptides and polynucleotids |
| 01/17/2012 | CA2429998C Intraocular implants for preventing transplant rejection in the eye |
| 01/17/2012 | CA2413195C Ligand to gpr8 and dna thereof |
| 01/17/2012 | CA2375214C Surfactant protein c esters |
| 01/17/2012 | CA2345208C Protective recombinant haemophilus influenzae high molecular weight proteins |
| 01/17/2012 | CA2320371C Inotropic and diuretic effects of exendin and glp-1 |
| 01/17/2012 | CA2264191C Recombinant toxin fragments |
| 01/17/2012 | CA2148712C Peripheralization of hematopoietic stem cells |
| 01/15/2012 | CA2746087A1 Use of preventing and treating inflammation |
| 01/12/2012 | WO2012006640A2 Compositions and methods useful in enhancement of memory |
| 01/12/2012 | WO2012006634A2 Prostate specific antigen (psa) peptide therapy |
| 01/12/2012 | WO2012006633A1 Chimeric clotting factors |
| 01/12/2012 | WO2012006624A2 Factor ix polypeptides and methods of use thereof |
| 01/12/2012 | WO2012006599A2 Compstatin analogs for treatment of rhinosinusitis and nasal polyposis |
| 01/12/2012 | WO2012006598A2 Stabilized insulinotropic peptides and methods of use |
| 01/12/2012 | WO2012006594A1 Method of producing recombinant adamts13 in cell culture |
| 01/12/2012 | WO2012006591A1 METHOD OF PRODUCING RECOMBINANT HIGH MOLECULAR WEIGHT vWF IN CELL CULTURE |
| 01/12/2012 | WO2012006585A2 Use of interleukin-15 to treat cardiovascular diseases |
| 01/12/2012 | WO2012006569A1 Methods for the prevention or treatment of no-reflow following ischemia/reperfusion injury |
| 01/12/2012 | WO2012006566A2 Microcrystalline y receptor agonists |
| 01/12/2012 | WO2012006512A1 Adenovirus ad36 e4orf1 protein for prevention and treatment of non-alcoholic fatty liver disease |
| 01/12/2012 | WO2012006510A1 Fatty acid protein kinase c activators and anticoagulant for the treatment of stroke |
| 01/12/2012 | WO2012006497A2 Mu opioid receptor agonist analogs of the endomorphins |
| 01/12/2012 | WO2012006437A2 Polypeptides having antiviral activity and methods for use thereof |
| 01/12/2012 | WO2012006384A2 Rothia species gluten-degrading enzymes and uses thereof |
| 01/12/2012 | WO2012006329A2 Apoe4 and apoj biomarker-based prevention and treatment of dementia |
| 01/12/2012 | WO2012006283A1 Compositions and methods for modulating the pharmacokinetics and pharmacodynamics of insulin |
| 01/12/2012 | WO2012006275A2 Treating non-hematopoietic cancer with interleukin 6 |
| 01/12/2012 | WO2012006149A2 Analogs of c5a and methods of using same |
| 01/12/2012 | WO2012006101A2 Blood substitutes and uses thereof |
| 01/12/2012 | WO2012006083A2 Targeted receptor-mediated sirna |
| 01/12/2012 | WO2012006027A1 Fzd8 extracellular domains and fzd8 extracellular domain fusion molecules and treatments using same |
| 01/12/2012 | WO2012005376A1 Composition for nucleic acid delivery, carrier composition, pharmaceutical composition using the composition for nucleic acid delivery or the carrier composition, and method for delivering nucleic acid |
| 01/12/2012 | WO2012005313A1 Cyclic peptide compound or pharmacologically acceptable salt thereof and method for producing same |
| 01/12/2012 | WO2012004966A1 Therapeutic agent for fibromyalgia containing etanercept |
| 01/12/2012 | WO2012004585A1 Ingestible formulation comprising glycomacropeptide and at least one of tryptophan, tyrosine and phenylalanine and uses thereof |
| 01/12/2012 | WO2012004554A1 Aldehyde compounds as inhibitors of dust mite group 1 peptidase allergen and their use |
| 01/12/2012 | WO2012004437A1 Novel serine protease inhibitor and use thereof |
| 01/12/2012 | WO2012004416A2 Treatment of a disease associated with retinal degenerative disorder |
| 01/12/2012 | WO2012004380A1 Diagnosis, prophylaxis and therapy of alzheimer's disease and other neurodementing disorders |
| 01/12/2012 | WO2012004291A1 Improved method for stem cell differentiation in vivo by delivery of morphogenes with mesoporous silica and corresponding pharmaceutical active ingredients. |
| 01/12/2012 | WO2012003960A1 Topical application of erythropoietin for the treatment of eye disorders and injuries |
| 01/12/2012 | WO2012003810A1 Regulatory factor of foxp3 and regulatory t cells and use thereof |
| 01/12/2012 | WO2011153590A8 Use of interferon epsilon in methods of diagnosis and treatment |
| 01/12/2012 | WO2011123842A9 Methods for treating parkinson's disease and other disorders of dopaminergic neurons of the brain |
| 01/12/2012 | WO2011112838A3 Composition and method for treatment of vascular hyperpermeability |
| 01/12/2012 | WO2003085121A9 Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer |
| 01/12/2012 | WO2002036070A3 Novel fish chemokine and methods for use |
| 01/12/2012 | US20120010599 Inorganically surface-modified polymers and methods for making and using them |
| 01/12/2012 | US20120010385 Splice variants of human g-protein coupled receptor hgprbmy29 (hgprmby29sv2) |
| 01/12/2012 | US20120010333 Composition comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof |
| 01/12/2012 | US20120010276 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
| 01/12/2012 | US20120010273 Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor |
| 01/12/2012 | US20120010159 Combination therapies with cox-2 inhibitors and treprostinil |
| 01/12/2012 | US20120010158 Tumor necrosis factor inhibiting peptides and uses thereof |
| 01/12/2012 | US20120010157 Method of stimulating the motility of the gastrointestinal system using ipamorelin |